9 -THC), accountable for the psychoactive effects of the plant, and CBD, the best known nonpsychotropic cannabinoid. Over 80 cannabinoids are known today, secreted by glands located in the head of hairs that cover the plant's flowers and leaves. The availability of these components in pure form stimulated the interest for the study of cannabis, with publications reaching their peak in the mid-1970s.
In this period, a group of Brazilian researchers led by Elisaldo Luiz de Araújo Carlini made significant progress in the study of the plant, especially in regard to the interactions among cannabinoids, demonstrating that the effects of cannabis could not be fully explained by the action of ∆ 9 -THC. In one of such interaction studies involving healthy volunteers, CBD was shown to attenuate the anxiety and psychotomimetic actions of elevated doses of ∆ 9 -THC, suggesting that CBD could have anxiolytic and/or antipsychotic properties. That was the beginning of a line of investigation followed by our research group until today 4 and that is described in the article entitled Therapeutical use of cannabinoids in psychiatry, included in this supplement. 5 The contradictory actions of cannabinoids on mental disorders are discussed in this supplement by two other articles, one dealing with the effects of cannabinoids in psychoses and the other with the abuse of cannabis by patients with mental disorders.
After the peak in the 1970s, the number of articles published in the area decreased for over a decade. However, in the end of the 1980s and beginning of the 1990s, the interest for the study of cannabis was renewed with the description and cloning of cannabinoid-specific receptors in the nervous system and the ensuing identification of endogenous ligands bound to these receptors. This subject is analyzed in detail in the article Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders?. 6 After these findings, the number of publications related to cannabis has increased almost tenfold from the 1980s to the current decade (ISI Web of Science - Figure 1) .
The amount of knowledge gathered by these investigations has contributed for the clarification of polemic questions related to cannabis, such as its effects on cognition and its potential to cause dependence and abstinence symptoms. These issues are "Ce qui est aujourd'hui un paradoxe pour nous sera pour la postérité une vérité démontrée" (That which today is a paradox to us will be tomorrow's truth).
Denis Diderot
Cannabis sativa: the plant that can induce unwanted effects and also treat them
Cannabis sativa: a planta que pode produzir efeitos indesejáveis e também tratá-los
